Partner Relations

Dear ATA Corporate Leadership Council Partners, ATA Leadership and ATA Faculty,

We extend our appreciation to all of you for joining us in Victoria on Saturday, October 21, 2017 for the Annual ATA Corporate Leadership Council Meeting.  The open dialogue and opportunity to meet in person to discuss the ever-changing landscape of the medical community and impact thereof for industry, physicians, and patients were uniquely valuable.  While fresh in our minds, we invite your further feedback via email on the issues we discussed as well as thoughts about other areas that may not have been covered. We look forward to following up in short order with a summary of the meeting and a brief survey.

We also want, again, to thank our corporate partners for their support. The need for this, and the tangible and intangible returns it provides in the form of improved outcomes, education and awareness in the health and scientific community, among patients and patient organizations, and at the level of local as well as state and federal government, continues to expand.

Our best wishes and regards,

Charles Emerson, MD, ATA President
Michael T. McDermott, MD, ATA Development Co-Chair
Connie Trump, PharmD, ATA Development Co-Chair

CLC Partner

Founded in 2010, the ATA Corporate Leadership Council (CLC) provides a unique and valuable forum for open communication between the ATA and the community of corporations that share interest in thyroid health and biology.

The ATA has created and made available at its web site this complete Institutional Conflict of Interest Disclosure, which will be updated annually.

Abbott India

Abbott India Limited (AIL) is one of India’s fastest growing pharmaceutical businesses. Headquartered in Mumbai, Abbott India Limited, is a publicly listed company (BSE: ABBOT) and a subsidiary of Abbott Laboratories, USA. The Company enjoys a leading presence in multiple therapeutic categories including Women’s Health, Gastroenterology, Neuro-psychiatry, Thyroid management and Liver health. Its success is driven by a combination of a highly competent and motivated team, R&D backed products, and strong alliances and partnerships with its suppliers and customers. Abbott India Limited reaches customers through a network of 25 distribution points which cater to over 5,200 stockists and 150,000 retail outlets. Visit us at:


AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.

Eisai, Inc.

100 Tice Boulevard

Woodcliff Lake, NJ 07677

As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., our passionate commitment to patient care is the driving force behind our efforts to help address unmet medical needs. We are a fully integrated pharmaceutical business with discovery, clinical, manufacturing and marketing capabilities. Our key areas of commercial focus include oncology and specialty care (Alzheimer’s disease, epilepsy and metabolic disorders). To learn more about Eisai Inc., please visit us at

Exelixis, Inc.

Exelixis is a biopharmaceutical company committed to developing and commercializing small molecule therapies for the treatment of cancer. We are committed to excellence in all aspects of our work and are dedicated to improving the care and outcome of cancer patients.

Genzyme Corporation

500 Kendall Street

Cambridge, MA 02142

Phone: (617) 252-7500

Genzyme, a Sanofi company, has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. With a focus on rare diseases and multiple sclerosis, we are dedicated to making a positive impact on the lives of the patients and families we serve. Visit

Quest Diagnostics

Quest Diagnostics offers comprehensive, integrated and innovative Thyroid Cancer Testing Solutions to provide you with the diagnostic insights you need to effectively diagnose and treat your patients. With nearly 800 M.D. and Ph.D level professionals we are a leader in the medical laboratory industry. We provide a comprehensive diagnostic portfolio for Thyroid Cancer, from screening and diagnosis to prognosis, treatment selection and monitoring. Our consultative network for Thyroid Pathology is comprised of board-certified pathologists with extensive experience in Thyroid Cancer. Find out more at

Mary Ann Liebert, Inc. Publishers

140 Huguenot Street, 3rd Floor

New Rochelle, NY 10801

Phone: (914) 740-2100

Mary Ann Liebert, Inc. publishes authoritative peer-reviewed journals in promising areas of science and biomedical research, including Thyroid, the Official Journal of the American Thyroid Association. Thyroid (, published in print and online monthly, is the leading, peer-reviewed resource for original articles, patient-focused reports, and translational research on thyroid cancer and all thyroid related diseases. The Journal delivers the latest findings on topics from primary care to clinical application, and is the exclusive source for the authoritative and updated ATA Guidelines for Managing Thyroid Disease.


6000 Shoreline Court, Suite 300

South San Francisco, CA 94080

Veracyte (NASDAQ: VCYT) is a leading genomic diagnostics company that is fundamentally improving patient care by resolving diagnostic uncertainty with evidence that is trustworthy and actionable. The company’s products uniquely combine genomic technology, clinical science and machine learning to provide answers that give physicians and patients a clear path forward without risky, costly surgery that is often unnecessary. Since its founding in 2008, Veracyte has commercialized three genomic tests, which are transforming the diagnosis of thyroid cancer, lung cancer and idiopathic pulmonary fibrosis and collectively target a $2 billion market opportunity. Veracyte is based in South San Francisco, California. For more information, please visit and follow the company on Twitter (@veracyte).

Spectrix Therapeutics, LLC

1256 Main Street, Ste 249
Southlake, TX 76092

Spectrix Therapeutics, LLC is a privately-held specialty pharmaceutical company committed to transforming how metabolic and endocrine disorders are treated pharmacologically. Through application of our proprietary multi-particulate drug delivery technologies we are able to provide tailored drug profiles to achieve optimal therapeutic effect, thereby enriching patient quality of life and further fueling the progress of medicine.




4545 Creek Road
Cincinnati, OH 45242

From creating the first sutures, to revolutionizing surgery with minimally invasive procedures, Ethicon, part of the Johnson & Johnson Medical Devices Companies, has made significant contributions to surgery for more than 60 years. Our continuing dedication to Shape the Future of Surgery is built on our commitment to help address the world’s most pressing health care issues, and improve and save more lives. Through Ethicon’s surgical technologies and solutions including sutures, staplers, energy devices, trocars and hemostats and our commitment to treat serious medical conditions like obesity and cancer worldwide, we deliver innovation to make a life-changing impact. Learn more at, and follow us on Twitter @Ethicon.